64
Views
4
CrossRef citations to date
0
Altmetric
Review

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

, &
Pages 419-429 | Published online: 24 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Floor E. Aleva, Frank L. van de Veerdonk, Yang Li, Rahajeng N. Tunjungputri, Sami Simons, Philip G. De Groot, Mihai M. Netea, Yvonne F. Heijdra, Quirijn de Mast & André J.A.M. van der Ven. (2018) The effects of signal transducer and activator of transcription three mutations on human platelets. Platelets 29:6, pages 602-609.
Read now
Estella M Davis, Jon T Knezevich & Robyn M Teply. (2013) Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor. Clinical Pharmacology: Advances and Applications 5, pages 67-83.
Read now
James J Nawarskas & Stanley S Snowden. (2011) Critical appraisal of ticagrelor in the management of acute coronary syndrome. Therapeutics and Clinical Risk Management 7, pages 473-488.
Read now

Articles from other publishers (1)

Mohamed S. Abbas, Mahmoud S. Abbas, Ali N. Harb, Roger K. Kakos, Kristian Loveridge & Hani H. Abujudeh. (2021) Periprocedural Anticoagulation and Antiplatelet Medications Management for Interventional Radiology Procedures. Current Radiology Reports 9:5.
Crossref